{
    "code": 0,
    "data": [
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For December 31 2025",
            "news_body": "Financial Results",
            "news_id": "0e0bdc87-3cc9-4001-96d2-76eef40aa989",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e202816c-42ee-4a19-905b-e48a4f275cc9.pdf",
            "news_date": "2026-01-21 14:57:03",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For September 30 2025\r\n",
            "news_body": "Unaudited Financial Results for the Quarter ended on 30-09-2025.",
            "news_id": "c173699f-011f-4c62-a4cb-36c0869dc4f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=765dc6e8-941f-4e17-9986-efa198d81c59.pdf",
            "news_date": "2025-11-14 16:56:29",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For June 30 2025",
            "news_body": "Financial Results for the quarter ended on 30-06-2025.",
            "news_id": "9a5620a1-5f57-4f9e-a79a-560429c7a6b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a3179ea9-ea0c-4fb6-a609-410c4e5a9818.pdf",
            "news_date": "2025-08-12 14:43:29",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For December 31 2024",
            "news_body": "Financial Results",
            "news_id": "78b0927f-319b-4708-a436-cb8c1380de43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6614a156-6189-4939-8d2f-3dafebb46d65.pdf",
            "news_date": "2025-02-11 14:43:44",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For September 30, 2024",
            "news_body": "Financial Results Consider and Approve",
            "news_id": "807c6ca5-b539-4cd5-a145-2ceec15bb050",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3e200f9-9c08-4cb9-b681-7644dd703701.pdf",
            "news_date": "2024-11-14 12:50:33",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For June 30, 2024",
            "news_body": "Financial Results for the quarter ended on 30th June, 2024.",
            "news_id": "b8967638-2c15-40a2-9802-0687d86cae28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b660e79-e771-4bad-89d3-38b4100abb0e.pdf",
            "news_date": "2024-08-08 12:00:06",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised Financial Results For The Period Of March 31, 2024",
            "news_body": "We are submitting the Revised Financial Results;<BR> <BR> The statement of Standalone Audited Financial Results of the Company for the period of March 31, 2024.",
            "news_id": "ad82648a-b940-42fe-8579-ab6272fbd948",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04799aac-271e-477e-ac79-8de11412c3e7.pdf",
            "news_date": "2024-05-17 15:57:03",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For March 31, 2024",
            "news_body": "Audited Financial Results for the year ended on 31st March, 2024.",
            "news_id": "90f4c5af-7161-49e1-a7fa-070790873846",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f030452-9ca9-44f2-8636-89053f1c479f.pdf",
            "news_date": "2024-05-02 17:38:14",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For December 31, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended on 31st December, 2023",
            "news_id": "f931e966-8caf-4520-824f-a25d4655ce6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1349166-a58d-445b-bdc3-e5a200cb82c2.pdf",
            "news_date": "2024-02-14 16:43:06",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For Sep 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter and half year ended on 30-09-2023.",
            "news_id": "c8044deb-2712-4693-af4c-3a8071bd350a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f3ba494-a5e2-490f-b22a-18524fde7928.pdf",
            "news_date": "2023-11-08 18:17:41",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For June 30, 2023",
            "news_body": "Unaudited Financial Results with Limited Review Report for the Quarter ended on 30-06-2023.",
            "news_id": "d31f0c61-8250-4824-ba36-b1af2fb7f965",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acafd10d-67c4-4b62-bdb8-8136dd5e9273.pdf",
            "news_date": "2023-08-12 19:01:31",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For March 31, 2023",
            "news_body": "We are submitting the Revised Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.We hereby enclose the following documents again.1. The Statement of Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2023.2. Auditors'' Report on Standalone Audited Financial Results. This File is also being made available on the website of the Company at www.indousagriseeds.com. Please take the same on your records.Thanking you,",
            "news_id": "c5f5018e-68ac-43f2-a322-a4b3f0b71321",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f8c4a6b-0db0-481f-9cd9-0a4211b70590.pdf",
            "news_date": "2023-05-03 16:43:57",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For Sep 30, 2022 (Unaudited)",
            "news_body": "With regard to the captioned subject and in compliance with the Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, This is to inform you under Regulation 30 and any other Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company was held on Monday, 14th Day of November, 2022 and said Board meeting commenced at 06.00 p.m. and concluded at 07:15 p.m. have inter- alia considered and approved:<BR> 1. The Un-audited Standalone financial results, Balance Sheet and Cash Flow Statement along with limited review report of the Company for the quarter and half year ended on 30th September, 2022.",
            "news_id": "34f92afe-6e47-4e13-a223-17d7dcd27475",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a263cea8-0d88-4172-b817-db558cbaaa01.pdf",
            "news_date": "2022-11-14 19:45:20",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015",
            "news_body": "It may please note that as per Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the compliance with the Corporate Governance Provisions as specified in regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27 and clauses (b) to (i) of sub-regulation (2) of regulation 46 and para-C, D and E of Schedule V shall not apply, in respect of having paid up equity share capital not  exceeding rupees Ten Crores and Net worth not exceeding rupees Twenty-Five Crore, as on the last day of the Previous financial year, The Listed Entity which has listed its specified securities on the SME Exchange. Since our Company does not have paid up equity and Net Worth of minimum level as per above referred regulation and it is listed under BSE SME Platform Therefore, our Company is not required to submit Related Party Transactions disclosure as required under Regulation 23(9) of the SEBI (LODR) Regulations, 2015.",
            "news_id": "3ff263b5-5398-4857-94ff-54754ea4588f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ea4f5f9-f9c3-4f85-b6e0-b5076f08b37e.pdf",
            "news_date": "2022-06-10 14:49:45",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised-Financial Results For March, 31, 2022",
            "news_body": "This is to inform that there was an inadvertent typo error in the submitted Standalone Financial Results dated 30.05.2022.<BR> Suo-motto we are submitting the Revised Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> We hereby enclose the following documents again.<BR> 1. Revised Statement of Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2022.<BR> 2. Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March, 2022.<BR> 3. Auditors'''' Report on Standalone and Consolidated Audited Financial Results.<BR> These Revised File is also being made available on the website of the Company at www.indousagriseeds.com.<BR> Please take the same on your records.",
            "news_id": "ba5bc391-6260-44b9-a49a-a8b7204e74a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e91d5e4-936b-495d-85a8-949980d65d09.pdf",
            "news_date": "2022-06-03 17:06:02",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Revised-Financial Results For March, 31, 2022",
            "news_body": "This is to inform that there was an inadvertent typo error in the submitted Standalone Financial Results dated 30.05.2022. <BR> Suo-motto we are submitting the Revised Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> We hereby enclose the following documents again.<BR> 1. Revised Statement of Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2022.<BR> 2. Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March, 2022.<BR> 3. Auditors'' Report on Standalone and Consolidated Audited Financial Results. <BR> These Revised File is also being made available on the website of the Company at www.indousagriseeds.com. <BR> Please take the same on your records.<BR>",
            "news_id": "c25141c9-544f-48d6-b8df-654b6e362385",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31c878e1-2f51-4402-b73f-a1c655c3a9fd.pdf",
            "news_date": "2022-06-03 16:33:20",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For March, 31 2022",
            "news_body": "With reference to above, we hereby inform that meeting of Board of Directors of the Company was held today (i.e., 30/05/2022), in which Board has approved and adopted the standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March, 2022.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following:  <BR> 1. Standalone and Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March, 2022.<BR> 2. Auditors'' Report on Standalone and Consolidated Audited Financial Results. <BR> <BR> These are also being made available on the website of the Company at www.indousagriseeds.com. <BR> <BR> Please take the same on your records.<BR> <BR> Thanking you,",
            "news_id": "1f08cbc0-5120-4ed8-87c3-fd2fdde65851",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=669dc7e7-7385-412f-979d-dadcf35fbf49.pdf",
            "news_date": "2022-05-30 18:38:45",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015",
            "news_body": "As per Regulation 23(9) SEBI (LODR) Regulations, 2015, every listed company shall be required to submit ''Disclosures of related party transactions on a consolidated basis'' within 30 days from the date of publication of its standalone and consolidated financial results for the half year.<BR> <BR> This is to inform you that, read with Regulation 15(2) of SEBI (LODR) Regulations, 2015, the above requirement shall not be applicable to our company as the Paid-up Share Capital is less than Rs. 10 Crore and Net Worth of the Company is less than Rs. 25 Crores as on 30/09/2021.<BR> <BR> The Company, therefore, is not required to submit ''Disclosures of the Related Party Transaction on a consolidated basis'' as per Regulation 23(9) of SEBI (LODR)Regulations, 2015.<BR> <BR> Kindly take the same on your record.",
            "news_id": "8cba5825-c774-4f3c-8a20-e38f0f9448b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=011e0e51-4245-4bf8-abf3-d2c10b579d96.pdf",
            "news_date": "2021-11-16 10:55:47",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For Sep 30, 2021",
            "news_body": "Dear Sir,<BR> With reference to captioned subject and pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Unaudited Standalone and Consolidated Financial Results, Balance Sheet, and Cash Flow Statement for the Quarter and Half year ended on 30th September, 2021, along with Limited Review Report for the half year ended on 30th September, 2021.<BR> <BR> Kindly take the same on your record and oblige us.<BR> <BR> Thanking you,",
            "news_id": "ed138dec-e02c-462c-92f3-feba618c36a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa20f912-706b-46dc-a8d3-ba415fdee02b.pdf",
            "news_date": "2021-11-14 16:42:45",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "INDOUS",
            "disp": "Indo Us Bio-Tech",
            "bse_code": 541304,
            "isin": "INE250Z01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results- Financial Results For March, 31 2021",
            "news_body": "With reference to above, we hereby inform that meeting of Board of Directors of the Company was held today (i.e., 30/06/2021), in which Board has approved and adopted the standalone and Consolidated Audited Financial Results of the Company for the Quarter and year ended 31st March, 2021.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following:  <BR> 1. Standalone and Consolidated Audited Financial Results of the Company for quarter and year ended on 31st March, 2021.<BR> 2. Auditors'' Report on Standalone and Consolidated Audited Financial Results. <BR> <BR> Pursuant to Regulation 33(3)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company have issued their audit reports with unmodified opinion for the Quarter and financial year ended on March 31, 2021.<BR>",
            "news_id": "6a8da6be-b005-4a4a-b96d-c7cecbb38b31",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddf08dfb-2bf7-41af-8319-ec39c9fa5b38.pdf",
            "news_date": "2021-06-30 17:59:14",
            "seo": "indo-us-biotech-ltd",
            "ltp": 130.42,
            "ch": 0.339999999999975,
            "pch": 0.2613776137761185,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 25503,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}